Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | bloom syndrome protein | 0.0023 | 1 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0023 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0023 | 1 | 1 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0023 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0381 | 0.0381 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.0023 | 1 | 1 |
Schistosoma mansoni | DNA helicase recq5 | 0.0023 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0023 | 1 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.8998 | 0.8998 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.8998 | 0.8998 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.8998 | 0.5 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0023 | 1 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0011 | 0.0381 | 0.0381 |
Echinococcus granulosus | bloom syndrome protein | 0.0023 | 1 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0023 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0023 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.8998 | 0.8958 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 1 | 1 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0023 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.8998 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.0023 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.8998 | 0.8998 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0023 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0023 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0023 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0381 | 0.00000000841 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.8998 | 0.5 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0023 | 1 | 1 |
Entamoeba histolytica | recQ family helicase, putative | 0.0023 | 1 | 1 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0023 | 1 | 1 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0023 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0023 | 1 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0023 | 1 | 1 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0011 | 0.0381 | 0.0423 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.8998 | 0.5 |
Entamoeba histolytica | recQ family DNA helicase | 0.0011 | 0.0381 | 0.0381 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.8998 | 0.8998 |
Loa Loa (eye worm) | RecQ helicase | 0.0023 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.8998 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.8998 | 0.8958 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0023 | 1 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.8998 | 0.8958 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 4.13 uM | Cytotoxicity against human CEM cells | ChEMBL. | 18439832 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 18439832 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.